ACTUATE THERAPEUTICS, INC. insider transactions

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78. — In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Filter rows

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 29 rows, 3 columns

Filter rows

Scroll sideways to compare all columns. Select a heading to sort.


Bios 2024 Co-Invest, LP	0002028708	1
BIOS Actuate Co-Invest I, LP	0001771378	6
BIOS Actuate Co-Invest II, LP	0001825398	6
Bios Actuate Co-Invest III, LP	0001956704	6
BIOS Advisors GP, LLC	0001813844	95
BIOS Capital Management, LP	0001813845	95
Bios Clinical Opportunity Fund, LP	0001988639	6
Bios Equity COF, LP	0002000747	6
Bios Equity Partners II, LP	0001813313	107
BIOS Equity Partners III, LP	0001831976	51
Bios Equity Partners, LP	0001813314	83
BIOS Fund I QP, LP	0001700297	83
BIOS Fund I, LP	0001697316	83
BIOS Fund II NT, LP	0001728851	107
BIOS Fund II QP, LP	0001716869	104
BIOS Fund II, LP	0001714576	107
BIOS Fund III NT, LP	0001791910	27
BIOS Fund III QP, LP	0001791916	30
BIOS Fund III, LP	0001791917	27
BP Directors, LP	0001813311	68
Cavu Advisors, LLC	0001813310	107
Cavu Management, LP	0001813270	113
Fletcher Aaron G.L.	0001789490	123
Kairos SPV Fund LLC	0001788046	1
Kairos Venture Opportunities I, L.P.	0001772438	1
Kairos Venture Partners II, L.P.	0001696711	2
Kairos-Actuate SPV, L.P.	0001835962	1
Kreis Leslie W.	0001813316	101
THOMSON TODD S	0001225707	2

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.